Zosano Pharma Corporation
ZSAN
ZSAN was delisted on the 10th of June, 2022.
34 hedge funds and large institutions have $13M invested in Zosano Pharma Corporation in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 9 closing their positions.
80% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 5
3% less funds holding
Funds holding: 35 → 34 (-1)
5% less capital invested
Capital invested by funds: $13.7M → $13M (-$713K)
11% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$1.24M |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$730K |
| 3 |
State Street
Boston,
Massachusetts
|
+$386K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$365K |
| 5 |
VF
Virtu Financial
New York
|
+$138K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$353K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$111K |
| 3 |
WG
Winton Group
London,
United Kingdom
|
-$80K |
| 4 |
Bank of New York Mellon
New York
|
-$52K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$40K |
ZSAN Hedge Fund Activity: Q2 2021 in Review
34 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Zosano Pharma Corporation (ZSAN) for Q2 2021, worth a combined $13M — down 5.2% from $13.7M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of ZSAN and 8 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 9 added.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $1.24M. The largest seller was BlackRock, cutting an estimated $353K.
- 34 institutional investors held Zosano Pharma Corporation (ZSAN) as of Q2 2021, down from 35 in Q1 2021.
- Funds reported $13M of Zosano Pharma Corporation stock for Q2 2021, down 5.2% quarter-over-quarter.
- 8 funds opened new Zosano Pharma Corporation positions in Q2 2021 and 9 closed out, a net change of -1 holder.
- The largest Zosano Pharma Corporation buyer in Q2 2021 was Renaissance Technologies, an estimated $1.24M added.
- The largest Zosano Pharma Corporation seller in Q2 2021 was BlackRock, an estimated $353K sold.
Based on aggregated 13F filings for Q2 2021.